Telik Q2 Loss Narrows

8/10/2012 8:29 PM ET

Clinical stage drug development company Telik, Inc. (TELK: Quote) posted second-quarter net loss of $2.1 million or $1.11 per share, narrower than $3.0 million or $1.67 per share in the previous year quarter.

Loss from operations narrowed to $2.06 million from $3.01 million in the comparable quarter last year.

Click here to receive FREE breaking news email alerts for TELIK INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 98 Articles

Editors Pick

King Loses Final Call For QE

Outgoing Bank of England Governor Mervyn King was outvoted in his final policy meeting, as most policymakers overturned his call for additional stimulus citing sustained economic recovery, the minutes of the session held on June 5 and 6 showed Wednesday. As seen in the past few months, King, Paul Fisher and David Miles sought an increase in quantitative easing by GBP 25 billion.

Cassini Spacecraft To Take Earth's Photo From Deep Space

NASA's Cassini spacecraft, now exploring Saturn, will take a picture of Earth from a distance of hundreds of millions of miles on July 19. NASA is inviting the public to help acknowledge the historic interplanetary portrait as it is being taken. Earth will appear as a small, pale blue dot between the rings of Saturn in the image, which will be part of a mosaic, or multi-image portrait, of the

Australia Leading Index Suggests Above-Trend Growth

A leading indicator of Australian economic activity continued to signal above-trend growth for the economy in the coming quarters, a report from Westpac and Melbourne Institute showed Wednesday. The annualized growth rate of the leading index, which indicates the likely pace of economic activity three to nine months into the future, was 5.4 percent in April, comfortably above its long term trend.